Synergy Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
1,390
+149
+12% +$152K 0.4% 49
2026
Q1
$1.14M Buy
1,241
+20
+2% +$20.3K 0.37% 49
2025
Q4
$1.31M Sell
1,221
-16
-1% -$15.3K 0.46% 42
2025
Q3
$944K Hold
1,237
– – 0.36% 46
2025
Q2
$964K Sell
1,237
-3
-0.2% -$2.33K 0.58% 27
2025
Q1
$1.02M Sell
1,240
-20
-2% -$16.6K 0.43% 46
2024
Q4
$972K Buy
+1,260
New +$1.04M 0.42% 42

Other funds holding LLY

Synergy Investment Management's LLY Position: Q2 2026 in Review

Synergy Investment Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $152K and bringing the position to 1,390 shares worth $1.67M. The position accounts for 0.4% of the portfolio, ranked #49.

Synergy Investment Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,643 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Synergy Investment Management held 1,390 shares of Eli Lilly worth $1.67M as of Q2 2026.
  • Synergy Investment Management bought 149 Eli Lilly shares in Q2 2026, an estimated $152K.
  • Eli Lilly made up 0.4% of Synergy Investment Management's portfolio in Q2 2026, its #49 holding.
  • Synergy Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,643 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Synergy Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.